Skip to main content
Zura Bio Ltd logo

Zura Bio Ltd — Investor Relations & Filings

Ticker · ZURA ISIN · KYG507521071 LEI · 549300LQXD6M2MIQFN24 US Manufacturing
Open in API
Filings indexed 394 across all filing types
Latest filing 2024-04-08 Regulatory Filings
Country KY Cayman Islands
Listing US ZURA

About Zura Bio Ltd

https://zurabio.com/

Zura Bio Ltd. is a multi-asset, clinical-stage biotechnology company focused on developing novel medicines for severe autoimmune and inflammatory disorders. The company's strategy centers on dual-pathway biology, aiming to create transformative solutions for patients whose needs are not adequately met by single-pathway medicines. Its development portfolio includes the therapeutic candidates tibulizumab (ZB-106), crebankitug (ZB-168), and torudokimab (ZB-880). Zura Bio's mission is to enhance patient well-being by developing innovative dual-pathway antibody therapies that demonstrate efficacy, safety, and dosing convenience for challenging immunological conditions.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 8, 2024, by Zura Bio Limited. It includes a Regulation FD Disclosure and a press release as Exhibit 99.1. The document explicitly states that the information is furnished and not filed, and it does not contain substantive financial statements or detailed financial data. The length is 4018 characters, which is relatively short and consistent with a current report or announcement rather than a full financial report. The content is typical of a current report (Form 8-K) used to announce material events or press releases, not an annual or quarterly report, earnings release, or other detailed financial filing. Therefore, the best classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2024-04-08 English
10-K
Annual Report FY 2023
2024-03-28 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated March 24, 2024, for Zura Bio Limited. It includes an announcement of the company's full fiscal year 2023 financial results via a press release (Exhibit 99.1) and details a management change, specifically the transition of the CEO. The key content is the CEO transition and the announcement of financial results through a press release, not the financial report itself. The document is about management changes and a current report filing, not a full annual report or earnings release. Therefore, the primary classification is Board/Management Information (MANG) due to the CEO transition announcement. The press release of financial results is referenced but not included as the report itself, so it does not qualify as an Earnings Release (ER). The document length (5522 characters) is just above the threshold but the content is focused on management change and a brief financial results announcement. Hence, the best fit is MANG with high confidence.
2024-03-28 English
FORM 8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated March 11, 2024, by Zura Bio Limited. It specifically references an attached Investor Presentation (Exhibit 99.1) dated March 2024. The text states that the presentation is being used for communications with banks and analysts and is incorporated by reference. The document does not contain detailed financial statements or comprehensive financial analysis itself but rather announces and furnishes an investor presentation. The length is just over 5,000 characters but the content is primarily an announcement of the presentation and its use, not the presentation itself or a full financial report. According to the "Menu vs Meal" rule, this is an announcement of a report (the investor presentation) rather than the report itself. Therefore, the filing type is best classified as Investor Presentation (IP).
2024-03-11 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text includes standard Form 8-K headings, references to Regulation FD Disclosure, and mentions an attached press release as Exhibit 99.1. There is no substantive financial data or detailed report content within the text itself, only a notification of the press release filing. The document length is 3707 characters, which is relatively short and consistent with a regulatory announcement rather than a full report. According to the rules, such filings that announce or furnish information without containing the full report or detailed financial data should be classified as Regulatory Filings (RNS).
2024-03-04 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details a change in the company's independent registered public accounting firm, including the termination of the prior auditor and engagement of a new auditor. It also discusses the absence of disagreements or reportable events with the prior auditor and includes a letter from the prior auditor as an exhibit. This type of filing is not a full audit report or annual report but rather an announcement of a change in the auditor, which falls under Board/Management Information or related announcements. However, since it concerns a change in the company's certifying accountant (auditor), it is best classified under Regulatory Filings (RNS) as it is a regulatory disclosure that does not fit the other more specific categories like Audit Report or Annual Report. The document length (7012 characters) and detailed content confirm it is not a mere announcement of a report but a substantive regulatory filing. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-02-23 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.